spironolactone has been researched along with dimethylarginine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujimura, K; Futatsugi, K; Hasegawa, K; Hayashi, K; Hosoya, K; Itoh, H; Kanda, T; Komatsu, M; Minakuchi, H; Shinozuka, K; Tokuyama, H; Wakino, S; Washida, N; Yoshifuji, A | 1 |
1 trial(s) available for spironolactone and dimethylarginine
Article | Year |
---|---|
Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Topics: Adipose Tissue; Aged; Aldosterone; Amidohydrolases; Animals; Arginine; Cell Nucleus; Cytochrome P-450 CYP11B2; Female; Glomerular Filtration Rate; Glucose Tolerance Test; Homeostasis; Humans; Immediate-Early Proteins; Insulin Resistance; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nephrectomy; Oxidative Stress; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renal Insufficiency, Chronic; Renin; Signal Transduction; Spironolactone | 2015 |